These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 161000)

  • 21. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
    Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
    N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative interactions at [3H]kainic acid binding sites in rat and human cerebellum.
    London ED; Coyle JT
    Eur J Pharmacol; 1979 Jun; 56(3):287-90. PubMed ID: 477725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme in substantia nigra: reduction of activity in Huntington's disease and after intrastriatal kainic acid in rats.
    Arregui A; Emson PC; Spokes EG
    Eur J Pharmacol; 1978 Nov; 52(1):121-4. PubMed ID: 214307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kainic acid binding to membranes of striatal neurons.
    Vincent SR; McGeer EG
    Life Sci; 1979 Jan; 24(3):265-70. PubMed ID: 423705
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellum.
    Kish SJ; Shannak KS; Perry TL; Hornykiewicz O
    J Neurochem; 1983 Nov; 41(5):1495-7. PubMed ID: 6137518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of kainic acid injection and cortical lesion on ornithine and aspartate aminotransferases in rat striatum.
    Wong PT; McGeer EG; McGeer PL
    J Neurosci Res; 1982; 8(4):643-50. PubMed ID: 6131142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of receptors for kainic acid on neurons in the innernuclear layer of retina.
    Biziere K; Coyle JT
    Neuropharmacology; 1979 Apr; 18(4):409-13. PubMed ID: 450206
    [No Abstract]   [Full Text] [Related]  

  • 28. Specific binding of kainic acid to purified subcellular fractions from rat brain.
    Nieto-Sampedro M; Shelton D; Cotman CW
    Neurochem Res; 1980 Jun; 5(6):591-604. PubMed ID: 6250092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficit of [3H]L-689,560 binding to the glycine site of the glutamate/NMDA receptor in the brain in Huntington's disease.
    Reynolds GP; Pearson SJ; Hutson PH
    J Neurol Sci; 1994 Aug; 125(1):46-9. PubMed ID: 7964888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
    Coyle JT; Ferkany JW; Zaczek R
    Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible decrease in dopaminergic 3H-agonist binding after 6-hydroxydopamine and irreversible decrease after kainic acid.
    Schweitzer BI; Bacopoulos NG
    Life Sci; 1983 Jan; 32(5):531-40. PubMed ID: 6296593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional brain atrophy and reductions in glutamate release and uptake after intrastriatal kainic acid.
    Friedle NM; Kelly PH; Moore KE
    Br J Pharmacol; 1978 May; 63(1):151-8. PubMed ID: 148306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activity of dopaminergic neurons of the substantia nigra following lesions of the neostriatum by kainic acid].
    Doudet D; Gross C; Bioulac B
    C R Seances Soc Biol Fil; 1984; 178(3):298-306. PubMed ID: 6238656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease.
    Wagster MV; Hedreen JC; Peyser CE; Folstein SE; Ross CA
    Exp Neurol; 1994 May; 127(1):70-5. PubMed ID: 7515353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia.
    Schoemaker H; Morelli M; Deshmukh P; Yamamura HI
    Brain Res; 1982 Sep; 248(2):396-401. PubMed ID: 6291702
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction of number of benzodiazepine binding sites in the caudate nucleus of the rat after kainic acid injections.
    Sperk G; Schlögl E
    Brain Res; 1979 Jul; 170(3):563-7. PubMed ID: 37987
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopa as an antimetabolite in Huntington's disease.
    Baskin F; Rosenberg RN
    Lancet; 1973 Mar; 1(7803):582-3. PubMed ID: 4120646
    [No Abstract]   [Full Text] [Related]  

  • 39. Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide.
    Freed WJ; Dillon-Carter O; Kleinman JE
    Exp Neurol; 1993 May; 121(1):48-56. PubMed ID: 7684336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.
    Mazziotta JC; Phelps ME; Pahl JJ; Huang SC; Baxter LR; Riege WH; Hoffman JM; Kuhl DE; Lanto AB; Wapenski JA
    N Engl J Med; 1987 Feb; 316(7):357-62. PubMed ID: 2949152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.